Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brain shuttle peptides derived from phage display.

Advances in pharmacology (San Diego, Calif.)·2026
Same author

Premature termination of early-phase cancer clinical trials: "It's the economy, stupid!"

Journal of the National Cancer Institute·2026
Same author

An emerging family of immunogenic epitopes in Chagas disease.

Trends in parasitology·2026
Same author

Decoding and deciphering a subcellular ZIP code system.

Trends in cell biology·2026
Same author

Endoscopic liquid biopsies of gastric fluid in a large human patient cohort reveal DNA content as a candidate tumor biomarker in gastric cancer.

eLife·2025
Same author

Leishmania amazonensis impairs phagosome acidification in B-1 phagocytes as an unrecognized parasite infection and proliferation mechanism.

Scientific reports·2025

Related Experiment Video

Updated: Jun 20, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Combinatorial ligand-directed lung targeting.

Ricardo J Giordano1, Julianna K Edwards, Rubin M Tuder

  • 1University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd-1374, Houston, TX 77030, USA.

Proceedings of the American Thoracic Society
|August 19, 2009
PubMed
Summary
This summary is machine-generated.

Phage display identifies lung blood vessel targeting peptides. These peptides aid in developing targeted nanoparticles for imaging and treating lung disorders, offering new therapeutic avenues.

More Related Videos

Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung
07:10

Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung

Published on: May 20, 2019

Related Experiment Videos

Last Updated: Jun 20, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung
07:10

Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung

Published on: May 20, 2019

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Vascular Biology

Background:

  • Phage display is a key method for discovering protein ligands and interaction partners.
  • In vivo phage display enables selection of peptides targeting specific vascular beds without prior receptor knowledge.
  • Vascular targeting leverages molecular differences in organ-specific and angiogenic blood vessels.

Purpose of the Study:

  • To discover peptides that specifically target lung vasculature using phage display.
  • To develop targeted nanoparticles for lung disorder imaging and drug delivery.
  • To explore the role of lung endothelial cell apoptosis in emphysema pathogenesis.

Main Methods:

  • Screening of random peptide libraries using immortalized lung endothelial cells.
  • In vivo phage display selections after intravenous administration of combinatorial libraries.
  • Characterization of lung vasculature-homing peptides and development of gold nanoparticles.

Main Results:

  • Identification of phage capable of homing to lung blood vessels.
  • Characterization of lung vasculature-targeting peptides with significant biological properties.
  • Development of targeted nanoparticles for imaging and drug delivery in lung disorders.
  • Insights into the role of lung endothelial cell apoptosis in emphysema.

Conclusions:

  • Ligand-directed discovery of lung vascular markers is crucial for targeted therapies.
  • Phage display technology combined with nanoparticles offers a promising platform for lung disorder treatment.
  • Targeted therapies hold potential for various airway diseases involving the endothelium.